A phase II study of Gleevec (imatinib mesylate formerly known as STI571) in chemotherapy refractory germ cell tumors expressing Kit
Latest Information Update: 26 Jan 2006
At a glance
- Drugs Imatinib (Primary)
- Indications Germ cell and embryonal neoplasms; Germ cell cancer
- Focus Therapeutic Use
- 26 Jan 2006 New trial record.